Codes / ICD10CM / C79.19

C79.19 Secondary malignant neoplasm of other urinary organs

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Secondary Malignant Neoplasm of Other Urinary Organs (ICD-10: C79.19)

Summary

Secondary malignant neoplasm of other urinary organs refers to cancer that has metastasized to specific urinary structures (excluding the bladder) from a primary tumor located elsewhere in the body. This condition is not primary urinary tract cancer but indicates the spread of an existing malignancy to organs such as the ureters, urethra, or renal pelvis.

Causes

This condition occurs when cancer cells from a primary tumor detach, travel through the bloodstream or lymphatic system, and establish new tumors in the urinary organs. Common primary sites include the lungs, breast, prostate, or colon, though the exact primary source may vary.

Risk Factors

  • History of a primary cancer, particularly those with high metastatic potential (e.g., lung, breast, prostate).
  • Advanced stage of the primary tumor.
  • Lack of effective treatment for the primary cancer.
  • Weakened immune system.
  • Genetic predisposition to aggressive cancer types.

Symptoms

  • Hematuria (blood in the urine)
  • Pelvic or lower abdominal pain
  • Frequent urination or urgency
  • Dysuria (painful urination)
  • Urinary obstruction or incontinence
  • Unexplained weight loss or fatigue

Diagnosis

Imaging tests such as CT scans, MRI, or PET scans are used to detect metastatic lesions in the urinary organs. Cystoscopy or ureteroscopy may be performed to visualize the affected areas, and biopsy of tissue samples confirms the presence of cancer cells.

Treatment Options

Treatment focuses on managing the primary cancer and metastatic disease, which may include chemotherapy, radiation therapy, or targeted therapies. Surgical intervention may be considered for symptom relief or to address obstructions.

Prognosis and Follow-Up

Prognosis depends on the primary cancer type, extent of metastasis, and response to treatment. Regular follow-up with imaging and clinical assessments is essential to monitor disease progression and manage symptoms.

Complications

  • Urinary tract obstruction leading to kidney damage.
  • Severe hematuria requiring intervention.
  • Infection or fistula formation.
  • Metastasis to other organs.

Lifestyle & Prevention

  • Maintain a healthy lifestyle to support overall cancer management.
  • Follow recommended screening for primary cancers to enable early detection.
  • Avoid known carcinogens (e.g., smoking) to reduce risk of primary malignancies.

When to Seek Professional Help

Seek medical attention if you experience persistent hematuria, unexplained pelvic pain, or changes in urinary habits, especially if you have a history of cancer.

Tips for Medical Coders

Document the specific urinary organ affected (e.g., ureter, urethra) and confirm the metastatic nature of the neoplasm. Ensure the primary cancer site is clearly identified to support accurate coding.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C79.19 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.